These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 349572)

  • 1. Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administration.
    Avogaro P; Bittolo-Bon G; Cazzolato G
    Pharmacol Res Commun; 1978 Feb; 10(2):127-31. PubMed ID: 349572
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between the plasma concentration of free nicotinic acid and some of its pharmacological effects in the fasted rat after an oral dose of sorbinicate and of nicotinic acid.
    Subissi A; Murmann W
    Arzneimittelforschung; 1978; 28(7):1143-5. PubMed ID: 582703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia.
    Carlson LA; Orö L; Ostman J
    Acta Med Scand; 1968 May; 183(5):457-65. PubMed ID: 4883477
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative evaluation of some pharmacological properties and side effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid.
    Subissi A; Schiantarelli P; Biagi M; Sardelli G
    Atherosclerosis; 1980 May; 36(1):135-48. PubMed ID: 7387773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some aspects of sorbinicate pharmacokinetics.
    Subissi A; Biagi M; Murmann W
    Arzneimittelforschung; 1980; 30(8):1278-84. PubMed ID: 7192142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of sorbinicate in the treatment of hyperlipoproteinemia type IIa and IIb].
    Guida L; Grimaldi S; Avella F; Marullo L; Mascio G
    Farmaco Prat; 1981 Jan; 36(1):13-22. PubMed ID: 7227491
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate).
    Uccella R; Morenghi R; Agosti C; Saponati G
    Artery; 1983; 11(5):400-12. PubMed ID: 6661043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nicotinic acid on the diurnal variation of the free fatty acids of plasma.
    Carlström S; Laurell S
    Acta Med Scand; 1968; 184(1-2):121-3. PubMed ID: 5317782
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of D-glucitol-hexanicotinate on platelet aggregability in patients with coronary heart disease.
    Sommariva D; Panigo FE; Rovelli L; Bonfiglioli D; Garimoldi M; Cialfi A; Gandini R; Fasoli A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):265-8. PubMed ID: 6746150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the relation between the mobilization of free fatty acids (FFA) and diabetic acidosis: effects of nicotinic acid].
    Vecchi GP; Salvioli GF; Marani L
    Rev Atheroscler (Paris); 1968; 10(1):20-5. PubMed ID: 4971277
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Effect of nicotinic acid analogue on plasma free fatty acids and ventricular arrhythmias after myocardial infarction.
    Rowe MJ; Oliver MF
    Br Heart J; 1974 Oct; 36(10):1037. PubMed ID: 4611459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antilipolytic activity of Sorbinicato. Clinical-pharmacological study].
    Magnati G; Bandini L; Pugnoli C; Strata A; Tirelli F; Zuliani U
    Farmaco Prat; 1978; 33(4):162-74. PubMed ID: 729773
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arteriosclerosis--nicotinic acid therapy. 5. Acute effects in man].
    Svedmyr N; Aberg G
    Lakartidningen; 1971 Apr; 68(15):1753-7. PubMed ID: 5577247
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute effect of a sustained release pyridyl carbinol preparation, ronicol retard, on plasma free fatty acids.
    Carlson LA; Orö L
    Acta Med Scand; 1969 Nov; 186(5):337-47. PubMed ID: 5378336
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics and antilipolytic effect of a derivative of nicotinic acid (sorbinicate) in dialyzed uremic patients].
    Zuliani U; Bonetti A; Orlandini G; Manari A; David S; Garini G
    Farmaco Prat; 1981 Sep; 36(9):416-23. PubMed ID: 7308427
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of indomethacin on flush induced by nicotinic acid in man.
    Svedmyr N; Heggelund A; Aberg G
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):397-400. PubMed ID: 335786
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical testing of the preparations SPN 40150 and N 150].
    Lietz W
    Z Allgemeinmed; 1973 Aug; 49(24):1135-6. PubMed ID: 4271794
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.